Company page

Minerva Neurosciences, Inc

Minerva Neurosciences, Inc. (ticker: NERV) is a public company based in the United States, specializing in the development of innovative therapies for central nervous system disorders. With a market capitalization of approximately $208.25 million, Minerva is focused on addressing unmet medical needs in the field of neuroscience. The company is committed to advancing its pipeline of drug candidates to improve patient outcomes.